Jinming Di
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer-related gene regulation 2
- Epigenetics and DNA Methylation 2
-
- Renal cell carcinoma treatment 4
- Prostate Cancer Treatment and Research 3
- Co-authors
- Zhi Shi (8 shared papers)Yun Luo (6 shared papers)Kejun Cheng (1 shared paper)Xing Wei (1 shared paper)Youqiu Xue (1 shared paper)Qiwei Jiang (5 shared papers)Minhua Lu (3 shared papers)Jieying Wu (1 shared paper)
- Journals
- Medicine (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Frontiers in Oncology (2 papers)Oncotarget (2 papers)Abdominal Radiology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Jinming Di
29 papers receiving 550 citations
Peers
Comparison fields: 5 of 97
- Geriatrics and Gerontology 51
- Cancer Research 87
- Molecular Biology 255
- Biochemistry 19
- Immunology 59
Countries citing papers authored by Jinming Di
This map shows the geographic impact of Jinming Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinming Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinming Di more than expected).
Fields of papers citing papers by Jinming Di
This network shows the impact of papers produced by Jinming Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinming Di. The network helps show where Jinming Di may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinming Di, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 97 | |
| 2 | 2016 | 69 | |
| 3 | Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing. | 2016 | 45 |
| 4 | 2015 | 40 | |
| 5 | 2015 | 38 | |
| 6 | 2009 | 35 | |
| 7 | 2020 | 33 | |
| 8 | 2019 | 26 | |
| 9 | 2022 | 26 | |
| 10 | 2009 | 25 | |
| 11 | 2015 | 22 | |
| 12 | 2018 | 21 | |
| 13 | 2019 | 13 | |
| 14 | Predictors of urinary continence recovery after modified radical prostatectomy for clinically high-risk prostate cancer. | 2015 | 10 |
| 15 | 2020 | 9 | |
| 16 | 2025 | 8 | |
| 17 | 2017 | 6 | |
| 18 | 2014 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2023 | 5 |
About Jinming Di
Jinming Di is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Pharmacology, Cancer Research and Surgery, having authored 32 papers that have together received 558 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Prostate Cancer Treatment and Research (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer-related gene regulation (2 papers), Epigenetics and DNA Methylation (2 papers), Vascular anomalies and interventions (2 papers), MicroRNA in disease regulation (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Geriatrics and Gerontology (51 citations), Cancer Research (87 citations), Molecular Biology (255 citations), Biochemistry (19 citations) and Immunology (59 citations). Jinming Di has collaborated with scholars based in China and United States. Frequent co-authors include Zhi Shi, Yun Luo, Kejun Cheng, Xing Wei, Youqiu Xue, Qiwei Jiang, Minhua Lu, Jieying Wu, Jun Pang and Wenji Zhang. Their work appears in journals such as Medicine, Oxidative Medicine and Cellular Longevity, Frontiers in Oncology, Oncotarget and Abdominal Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.